SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michelle Sexton, Eiron Cudaback, Rehab A. Abdullah, John Finnell, Laurie K. Mischley, Mary Rozga, Aron H. Lichtman, Nephi Stella, Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters, Inflammopharmacology, 2014,

    CrossRef

  2. 2
    Paula Suárez-Pinilla, José López-Gil, Benedicto Crespo-Facorro, Immune system: A possible nexus between cannabinoids and psychosis, Brain, Behavior, and Immunity, 2014, 40, 269

    CrossRef

  3. 3
    J.A. Lederer, Pathobiology of Human Disease, 2014,

    CrossRef

  4. 4
    Ismael Galve-Roperh, Valerio Chiurchiù, Javier Díaz-Alonso, Monica Bari, Manuel Guzmán, Mauro Maccarrone, Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation, Progress in Lipid Research, 2013, 52, 4, 633

    CrossRef

  5. 5
    Dario Siniscalco, Anna Sapone, Catia Giordano, Alessandra Cirillo, Laura de Magistris, Francesco Rossi, Alessio Fasano, James Jeffrey Bradstreet, Sabatino Maione, Nicola Antonucci, Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders, Journal of Autism and Developmental Disorders, 2013, 43, 11, 2686

    CrossRef

  6. 6
    Barbara L.F. Kaplan, The role of CB1 in immune modulation by cannabinoids, Pharmacology & Therapeutics, 2013, 137, 3, 365

    CrossRef

  7. 7
    Sara E. Rosenquist, Is Oral Sex Really a Dangerous Carcinogen? Let's Take a Closer Look, The Journal of Sexual Medicine, 2012, 9, 9
  8. 8
    Udai P. Singh, Narendra P. Singh, Balwan Singh, Lorne J. Hofseth, Dennis D. Taub, Robert L. Price, Mitzi Nagarkatti, Prakash S. Nagarkatti, Role of resveratrol-induced CD11b+ Gr-1+ myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3+ T cells and amelioration of chronic colitis in IL-10−/− mice, Brain, Behavior, and Immunity, 2012, 26, 1, 72

    CrossRef

  9. 9
    Guillermo Velasco, Cristina Sánchez, Manuel Guzmán, Towards the use of cannabinoids as antitumour agents, Nature Reviews Cancer, 2012, 12, 6, 436

    CrossRef

  10. 10
    Ibrahim H. Younos, Alicia J. Dafferner, Dumrul Gulen, Holly C. Britton, James E. Talmadge, Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking, International Immunopharmacology, 2012, 13, 3, 245

    CrossRef

  11. You have free access to this content11
    BiotecVisions 2011, January, Biotechnology Journal, 2011, 6, 1
  12. 12
    Jonathan Hoggatt, Louis M Pelus, Many mechanisms mediating mobilization: an alliterative review, Current Opinion in Hematology, 2011, 18, 4, 231

    CrossRef

  13. 13
    Ramón Gimeno, Jordi Barquinero, Myeloid-derived suppressor cells (MDSC): Another player in the orchestra, Inmunología, 2011, 30, 2, 45

    CrossRef

  14. 14
    Y. M. Ambrosini, G.-X. Yang, W. Zhang, M. Tsuda, S. Shu, K. Tsuneyama, P. S. C. Leung, A. A. Ansari, R. L. Coppel, M. E. Gershwin, The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis, Clinical & Experimental Immunology, 2011, 166, 1
  15. You have free access to this content15
    Alberto Mantovani, The growing diversity and spectrum of action of myeloid-derived suppressor cells, European Journal of Immunology, 2010, 40, 12